home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Reducing The Pain Of Stem Cell Therapy

  February, 22 2005 8:20
your information resource in human molecular genetics
Stem cell transplantation holds the promise of recovery from debilitating spinal cord injury. Now, a paper in the March issue of Nature Neuroscience reports that the treatment can also worsen a problem suffered by some spinal cord injury patients.

In this condition, called allodynia, normally painless stimuli become painful. The authors showed that this side effect could be prevented by using gene transfer to control the type of cells produced from the transplanted stem cells.

Looking at recovery in rats with spinal cord injury, Christoph Hofstetter and his colleagues found that rats who received neural stem cells harvested from the spinal cord of other rats did recover some motor function as a result. However, they also developed allodynia in their forepaws, reacting to normal stimuli -- such as cold and pressure -- as if they were painful. This increased sensitivity was suggested to be due to abnormal axon growth in these animals.

Another group of animals received stem cells that had been infected with the gene for neurogenin2 before transplantation, which prevents them from differentiating into a type of brain cell called astrocytes. These rats showed even better recovery, without the allodynia and also had less abnormal axon growth.

These results show that stem cell transplantation may be useful in treating spinal cord injuries, but it can also cause serious side effects, which should be considered in the planning of human clinical trials.

Author contact:

Christoph P Hofstetter
Karolinska Institute
Stockholm, Sweden
Tel: +46 85 24 87 062
E-mail: christoph.hofstetter@neuro.ki.se

Additional contact for comment on paper:

Clive Svendsen
Univ. of Wisconsin Medical School
Madison, WI
Tel: +1 608 265 8668
E-mail: svendsen@waisman.wisc.edu

Also available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.